Clinical Trial Update: REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL) [Phase 3]

View source ↗

Summary

Phase 3 trial REMOVAL investigated metformin's effect on vascular adverse lesions in adults with type 1 diabetes; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Glasgow | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2019-06-03